C4 Therapeutics
CCCC
CCCC
118 hedge funds and large institutions have $366M invested in C4 Therapeutics in 2024 Q3 according to their latest regulatory filings, with 30 funds opening new positions, 38 increasing their positions, 30 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
118
Holders Change
+3
Holders Change %
+2.61%
% of All Funds
1.71%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
30
Increased
38
Reduced
30
Closed
26
Calls
$4.89M
Puts
$941K
Net Calls
+$3.95M
Net Calls Change
+$1.6M
Top Buyers
1 |
O
OrbiMed
New York
|
$25M |
2 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
$37.6M |
3 |
Morgan Stanley
New York
|
$13.3M |
4 |
Point72 Asset Management
Stamford,
Connecticut
|
$6.85M |
5 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
$32.4M |